Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis
Open Access
- 3 October 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 396 (10256), 968-976
- https://doi.org/10.1016/s0140-6736(20)31964-4
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- The Genotype-Tissue Expression (GTEx) projectNature Genetics, 2013
- Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical OutcomesJournal of Cardiac Failure, 2009
- The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countriesAmerican Heart Journal, 2009
- Common Coding Variants of the HNF1A Gene Are Associated With Multiple Cardiovascular Risk Phenotypes in Community-Based Samples of Younger and Older European-American AdultsCirculation: Cardiovascular Genetics, 2009
- Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the HeartCirculation Research, 2008
- ACE2 Deficiency Modifies Renoprotection Afforded by ACE Inhibition in Experimental DiabetesDiabetes, 2008
- The Type and the Position of HNF1A Mutation Modulate Age at Diagnosis of Diabetes in Patients with Maturity-Onset Diabetes of the Young (MODY)-3Diabetes, 2008
- ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway EpitheliaJournal of Virology, 2005
- Tumor Necrosis Factor-α Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-acute Respiratory Syndrome-Coronavirus (SARS-CoV) Receptor, Angiotensin-converting Enzyme-2 (ACE2)Online Journal of Public Health Informatics, 2005
- Angiotensin-converting enzyme 2 is an essential regulator of heart functionNature, 2002